Infectious bursal disease virus (IBDV), a non-enveloped double-stranded RNA virus of chicken, encodes five proteins. Of these, the RNA-dependent RNA polymerase (VP1) is specified by the smaller genome segment, while the large segment directs synthesis of a non-structural protein (VP5) and a structural protein precursor from which the capsid proteins pVP2 and VP3 as well as the viral protease VP4 are derived. Using the recently redefined processing sites of the precursor we have reevaluated the homotypic interactions of the viral proteins using the yeast two-hybrid system. Except for VP1, which interacted weakly, all proteins appeared to selfassociate strongly. Using a deletion mutagenesis approach we subsequently mapped the interacting domains in these polypeptides, where possible confirming the observations made in the two-hybrid system by performing coimmunoprecipitation analyses of tagged protein constructs co-expressed in avian culture cells. The results revealed that pVP2 possesses multiple interaction domains, consistent with available structural information about this external capsid protein.
INTRODUCTION
Infectious bursal disease (IBD), also known as Gumboro disease, is an acute contagious viral disease of young chickens that is of major importance for the poultry industry (Cheville, 1967) . The IBD virus (IBDV) causes a severe immunosuppression by destroying B-lymphoid cells present in the bursa of Fabricius followed by bursal atrophy. The immunosuppression leads to an increased susceptibility to other pathogens and reduces the growth rate of surviving animals (Kibenge et al., 1988) . To date, two distinct serotypes (I and II) of IBDV have been identified (Jackwood et al., 1982) . The pathogenic serotype I viruses are isolated from chickens and vary in virulence. Serotype II viruses are nonpathogenic and occur in turkeys and chickens (Jackwood et al., 1982; McFerran et al., 1980) . contain a double-stranded RNA (dsRNA) genome consisting of two segments, designated A and B, within an unenveloped single-shelled icosahedral capsid of 60 nm in diameter (Dobos et al., 1979; Muller et al., 1979) . The smaller segment B (approximately 2.9 kb) encodes viral protein 1 (VP1; 95 kDa), the putative RNAdependent RNA polymerase (RdRp) (Bruenn, 1991; Macreadie & Azad, 1993; Spies et al., 1987) . This polypeptide is present in the virion both as a free protein and as a genome-linked protein, called VPg, attached to the 5' end of the positive strands of the two genomic segments (Dobos, 1993; Spies & Muller, 1990) . Segment A (approximately 3.3 kb) contains two partially overlapping open reading frames (ORFs). The first, smaller ORF encodes nonstructural protein VP5, which is not essential for viral replication in vitro but important for virus-induced pathogenicity Yao et al., 1998) . The larger ORF encodes a 110 kDa polyprotein that is autocatalytically cleaved, rendering three polypeptides: pVP2 (48 kDa), VP3 (32 kDa) and VP4 (28 kDa). VP4, a serine-lysine protease (Birghan et al., 2000) , is responsible for this self-processing (Lejal et al., 2000; Sanchez & Rodriguez, 1999) . It is a nonstructural protein mainly associated with type II tubules of 24 nm in diameter (Granzow et al., 1997) . pVP2 is further processed at its carboxy terminus to become VP2 (40 kDa) Lejal et al., 2000) . VP2 and VP3 are the structural proteins forming the outer and inner layers of the virion, respectively (Bottcher et al., 1997; Caston et al., 2001 ). Recently we showed that VP3 interacts not only with VP1 but also with the genomic dsRNA segments A and B, the former interaction being of crucial importance for IBDV replication (Tacken et al., 2002) .
Interactions among viral proteins and between viral and host proteins play a central role in the infection process. These interactions include transient as well as long-lived associations. Often, these interactions establish essential functional complexes responsible for processes such as viral genome replication, RNA transcription and translation, virus assembly and virus release. Identification of such protein-protein interactions is therefore of vital importance for a better understanding of the dynamics of viral multiplication.
We have recently been using the yeast two-hybrid system in various interaction studies of the IBDV proteins. Thus, we detected a number of candidate cellular interaction partners for the IBDV proteins VP1, pVP2, VP3 and VP5 (Tacken et al., 2001) . One of these was further explored revealing an interaction between VP1 and translational eukaryotic initiation factor 4AII (eIF4AII) (M.G.J. Tacken, A.A.M. Thomas, B.P.H. Peeters, P.J.M. Rottier and H.J. Boot, submitted) . We also used this system to analyse the intermolecular interactions between the IBDV proteins themselves (Tacken et al., 2000) . Though the yeast assays did not allow us to detect an interaction between the two capsid proteins pVP2 and VP3, an interaction between the latter and VP1, presumed to draw the polymerase into assembling viral particles, was clearly demonstrated. Whereas these studies also revealed homotypic interactions of the IBDV structural proteins, the recent redefinition o processing scheme of the structural protein precursor (Lejal et al., 2000; Sanchez & Rodriguez, 1999 ) now casts some doubt on these observations. In the present study we have first re-evaluated our earlier findings based on the newly established processing sites.
This confirmed the homotypic interactions found for pVP2, VP3, VP4 and VP5, which we now also demonstrated by co-immunoprecipitation of co-expressed tagged and untagged forms of the proteins. We subsequently carried out deletion studies to map the self-interacting domains in each of these proteins. It appears that the different proteins interact through different domains which for the VP3 protein identified yet another domain in addition to the ones shown recently to be involved in associating with VP1 and with genomic dsRNA of both segment A and B.
MATERIALS AND METHODS

CELL LINE, VIRUS, PLASMID, AND BACTERIAL AND YEAST STRAINS
QM5 cells (Antin & Ordahl, 1991) were cultured in QT35 medium (Gibco-BRL) supplemented with 5 % fetal calf serum (FCS) and 2% antibiotic solution ABII (1,000 U of penicillin [Yamanouchi] , 1 mg of streptomycin [Radiumfarma] , 20 µg of amphotericin B [Fungizone] , 500 µg of polymixin B, and 10 mg of kanamycin/ml) in a CO 2 (5%) incubator at 37°C. Recombinant fowlpox virus expressing the T7 polymerase gene (FPV-T7) (Britton et al., 1996) was received from the laboratory of M. Skinner (Compton Laboratory, Berks, United Kingdom). The preparation of the plasmid pHB36W, which contains the full-length genomic cDNA of segment A of IBDV strain CEF94, has been described (Boot et al., 1999) . Escherichia coli (E. coli) strain DH5-α (Life Technologies) was used during DNA manipulations. Yeast strain Saccharomyces cerevisiae (S. cerevisiae) EGY48 (MATα, his3, trp1, ura3, LexA op(x6) -LEU2) was used for the yeast two-hybrid analyses. Yeast strain S. cerevisiae EGY48[p8oplacZ] is the host strain EGY48 transformed with the autonomously replicating reporter plasmid p8op-LacZ (Clontech).
CONSTRUCTION OF TWO-HYBRID EXPRESSION PLASMIDS
The plasmids pLexA BD -VP1, pLexA BD -VP5, pB42 AD -VP1, pB42 AD -VP5, containing the cDNA sequence encoding VP1 or VP5 of IBDV strain CEF94, have been described previously (Tacken et al., 2000) . Copy DNA encoding the full-length sequences of pVP2, VP3 and VP4 of IBDV strain CEF94, as well as defined parts of VP5, pVP2, VP3, and VP4 (see Fig. 2 ), were amplified by PCR by using the Expand high fidelity PCR system (Boehringer Mannheim). Plasmid pHB36W was used as a template. The sets of primers used were designed to introduce an EcoRI site at the upstream (5') end and a stop codon plus either a SalI site or a XhoI site at the downstream (3') end of each coding sequence (Table 1 
TWO-HYBRID ANALYSIS
All two-hybrid media, buffers, and protocols were as described in the Clontech Table 2 LacZ reporter gene whose expression is driven by the yeast GAL1 promoter.
However, two LexA operators have been placed between the GAL1 promoter and the lacZ gene. When a LexA BD fusion protein binds to these operators there will be a decrease in the level of GAL1-driven lacZ expression. A liquid assay to quantify ß-galactosidase activities was performed by growing transformants to mid log phase in the appropriate selection medium, SD/Gal/Raf/-Ura or SD/Gal/Raf/-His/-Ura, and using O-nitrophenyl-ß-D-galactoside as the chromogenic substrate. Each enzyme activity assay was performed with at least five independent colonies and ß-Galactosidase specific activities were calculated as described by Clontech.
CONSTRUCTION OF THE EXPRESSION PLASMIDS FOR CO-IMMUNOPRECIPITATION
ANALYSIS
The c-Myc-tag and hemagglutinin (HA)-tag fusions were cloned as follows. The pVP2, VP3, VP4, VP5 (or defined parts thereof) containing inserts were excised from their respective pLexA BD -vectors described above, through restiction enzyme digestion with either EcoRI/XhoI or EcoRI/SalI. These fragments were gel purified by the QIAEX-II method (QIAGEN) and ligated with T4 ligase (New England BioLabs) into the vectors pGBKT7 and pGADT7 (Clontech). The vector pGBKT7 had previously been digested with EcoRI/SalI and the vector pGADT7 with EcoRI/XhoI. The ligation mix was transformed into E. coli DH5-α cells, which were subsequently grown either under kanamycin (pGBKT7) or ampicillin (pGADT7) selection. Plasmid DNA prepared from several independent transformants was screened for the presence of the insert, and plasmids from positive clones were sequenced at the fusion junction by cycle sequencing using an ABI 310 sequencer (PE Applied Biosystems) to ensure correct reading frames.
TRANSFECTION OF QM5 CELLS
QM5 cells were grown to 80% confluency in 60-mm dishes and infected with FPV-T7
(multiplicity of infection [MOI] = 3). After 1 h, the cells were washed once with 5 ml QT35 medium and covered with 5 ml of Optimem 1 (Gibco-BRL). In the meantime, 2.0 µg of DNA was mixed with 25 µl Lipofectamine (Gibco-BRL) in 0.5 ml Optimem 1 and kept at room temperature for at least 30 min. The QM5 cells were subsequently covered with 4 ml of fresh Optimem 1, and the DNA-Lipofectamine mixture was added. The transfection was performed overnight (18 h) in a 37°C incubator (5.0%
CO 2 ). The transfected monolayer was rinsed once with QT35 medium and fresh QT35 medium supplemented with 5% FCS and 2% ABII was added, and the plates were incubated for another 24 h.
RADIOLABELING OF TRANSFECTED CELLS AND IMMUNOPRECIPITATION
At 48 h post-transfection, cells were starved for 1 h in methionine-free EMEM medium (Gibco-BRL). Cells were then labeled for 3 h with 20 µCi/ml of [ 
RESULTS
INTERACTIONS OF pVP2, VP3, pVP4, VP1 AND VP5 WITH THEMSELVES AND EACH OTHER ASSAYED IN THE YEAST TWO-HYBRID SYSTEM
The ability of the full-length viral proteins, VP1, pVP2, VP3, VP4 and VP5 to interact with themselves or with each other was re-evaluated using the polypeptides pVP2, VP3 and VP4 based on the corrected polyprotein cleavage sites (compare Fig. 1C with 1D). cDNA fragments of IBDV strain CEF94 encoding these polypeptides were generated by PCR and subcloned into the plasmids pLexA BD and pB42 AD for two- (Hudson et al., 1986) and (B) based on the recently corrected cleavage sites (Lejal et al., 2000; Sanchez and Rodriguez, 1999) . (C and D) Schematic representation of the polypeptides used for the two-hybrid analysis;
(C) previously used (Tacken et al., 2000) and (D) currently used. The first and last amino acid as well as the position of expressed regions are indicated.
galactosidase (β-gal) as observed by the appearance of blue colonies on X-Galcontaining medium. The strength of the protein-protein interaction was judged by the intensity of the bleu phenotype or by the time required for growth on mediumlacking leucine. At least seven independent transformants of each strain were screened. Additionally, all fusions were tested for intrinsic or nonspecific activation. The pB42 AD fusion plasmids were co-transformed with LexA fused to the human Lamin C protein to test for specificity of interaction with each of the BD fusions while all the pLexA BD fusion plasmids were co-transformed with an empty AD to test for intrinsic activation. None of the fusions did intrinsically or nonspecifically activate expression of the LEU2 and LacZ reporters, confirming the specificity of the test system for IBDV proteins. Plasmids containing sequences encoding p53 fused to
LexA and plasmids with sequences of SV40 large T antigen fused to B42, were coLexA BD fusion: VP1 pVP2 VP3 VP4 VP5 Lamin C 53 (Tables 2 and 3 ).
When we compare these results with those obtained previously (Tacken et al., 2000) , there is one apparent difference. The homologous interaction of VP4, which we clearly observe in our present study, was not detected in our earlier work.
Apparently, the amino-terminal extension abolished the protein's ability to interact with itself.
DELETION MAPPING OF THE SELF-INTERACTING DOMAINS OF THE IBDV PROTEINS USING THE YEAST TWO-HYBRID SYSTEM
To study the domains involved in the homotypic interactions of the pVP2, VP3, VP4 and VP5 proteins, five different deletion mutants were initially generated for each protein ( Fig The results of the assays are presented in Fig. 2 . Of the pVP2 deletion mutants all truncated fusion proteins scored positive in the β-gal and Leu ⎯ growth tests, albeit with some variation in interaction strength ( Fig. 2A, no. 2-6 ). The observation that both the amino-terminal and the carboxy-terminal half of the pVP2 protein were able by themselves to interact with the full-size polypeptide suggests that the homotypic interactions between pVP2 molecules are based on more than one contact site. For VP3 the critical domains for interaction are located in the amino-terminal part. Carboxy-terminal deletion of one-fourth or half of the protein as in VP3∆C64 and VP3∆C129 was without measurable effect on the strength of the interaction with full-length VP3 (Fig. 2B, no. 2-3) . Truncations, however, by 64 and 129 amino acids at the amino terminus were detrimental for their interaction with fulllength VP3: the scores with these polypeptides were (very) weak or even negative (Fig. 2B , no. 4-6). VP4-VP4 interaction appeared to be extremely sensitive to modifications. Any deletion that we applied appeared to be invariably lethal (Fig.   2C , no. 2-6). VP5-VP5 association on the other hand was quite tolerant to deletions.
All truncations except for the construct VP5∆C73 (Fig. 2D, no. 3), which lacks the sequence for the carboxy-terminal half of the protein, scored positive in both the β-gal and Leu ⎯ growth test (Fig. 2D, no. 2-6 ). These results suggest that REGION III is responsible for VP5 homomeric interaction.
FINE MAPPING THE SELF-INTERACTION SITES OF VP3 AND VP5 USING THE YEAST TWO-HYBRID SYSTEM
To determine the putative self-interacting domain of VP3 and VP5 more precisely, we constructed and tested four additional progressive deletion mutants for each protein.
For VP3 a series of constructs was generated encoding internal core protein fragments (Fig. 2B , no. 7-9) as well as an amino-terminal protein fragment (Fig. 2B, no. 10), each comprising a part of REGION I and/or II. When these constructs were assayed in the yeast two-hybrid system homotypic interactions were observed for all these polypeptides, though for three of them the interaction strength measured in the pairing of pLexA BD -VP3(deletion mutant) with pB42 AD -VP3(full-length) was significantly lower than that in the reciprocal pairing of pB42 AD -VP3(deletion mutant) with pLexA BD -VP3(full-length) (Fig. 2B , no. 7, 9 and 10). Such polarity of two-hybrid interactions has frequently been observed (Cuconati et al., 1998; Xiang et al., 1995) and is most likely an inherent consequence of the two-hybrid assay. The fused LexA BD -or B42 AD -domain might partly occlude the site of interaction, or the fusion proteins may be folded improperly, be unstable or poorly expressed. The VP3 mutant termed VP3∆N32/C129, however, interacted in both its polarities with the fulllength VP3 (Fig. 2B , no. 8) as strongly as full-length VP3 interacted with itself (Fig. 2B, no. 1). Based on these results we conclude the internal core protein fragment encompassing residues 33 to 129 (i.e. REGION II and half of REGION I) to be essential for VP3 homomeric interaction (Fig. 2B , region between dotted lines).
The constructs that were generated for the further mapping of the interaction site in VP5 consisted either of the complete REGION III (Fig. 2D, 
HOMOLOGOUS INTERACTIONS OF THE FULL-LENGTH IBDV PROTEINS pVP2, VP3 AND VP4 ASSAYED BY CO-IMMUNOPRECIPITATION ANALYSIS
To obtain corroborating evidence for the interactions detected by the two-hybrid analyses, we employed a radio-immunoprecipitation (RIP) assay using a cotransfection system in which the respective proteins are transiently co-expressed in QM5 cells. To this end, we used plasmid pHB36W, in which the full-length genomic cDNA of segment A of IBDV is cloned in a transcription plasmid between a T7 RNA polymerase promoter and the autocatalytic hepatitis delta virus ribozyme sequence (Boot et al., 1999) . Furthermore, for the co-expression of the viral proteins we used the transcription plasmid pGBKT7, in which the cDNA of each of the viral proteins, pVP2, VP3, VP4 and VP5, was cloned behind a T7 RNA polymerase promoter sequence, in fusion with a sequence encoding the c-Myc epitope tag. By using these tagged fusion proteins and anti-c-Myc antibodies, it was possible to specifically precipitate only one of the two homologous interacting proteins and to distinguish these proteins by a difference in their electrophoretic mobility (i.e. recombinant fowlpox virus that expresses T7 RNA polymerase (Britton et al., 1996) .
Forty-eight hours post-transfection, cells were metabolically labeled for 3 hours with proteins additionally interacted with themselves, whereas tagged VP4 did not, or to a lesser extent.
FINE MAPPING OF HOMOTYPIC INTERACTIONS OF VP3 AND VP5 BY CO-IMMUNOPRECIPITATION ANALYSIS
Using this in vivo co-immunoprecipitation assay, we additionally analyzed several VP3 and VP5 truncation mutants assayed earlier in the two-hybrid system ( and the HA-antibodies lacked cross-reactivity against the respective fusion-proteins (data not shown). When using the c-Myc antibodies for the precipitation of c-Myctagged VP3, only the HA-tagged mutant proteins VP3∆C129 and VP3∆C161 were found to be co-precipitated (Fig. 4A, lanes 1 and 6) . The same result was observed when using the HA-antibodies, where c-Myc-tagged full-length VP3 was only coprecipitated with the HA-tagged VP3∆C129 and VP3∆C161 proteins (Fig. 4A, lanes 8 and 13). Furthermore, reversing the c-Myc-and HA-tags did not affect the observed interactions, thus confirming the results (Fig. 4B, lanes 1, 6, 8 and 13 ). In addition, an interaction was observed for mutant protein VP3∆N32/C129, though weak and only in one orientation. When using the c-Myc antibodies, HA-tagged full-length VP3 was observed to be co-precipitated with the HA-tagged VP3∆N32/C129 (Fig. 4B, lane 4) .
For VP5, none of the deletion mutants tested was found to be co-precipitated with full-length VP5, either way and irrespective of the orientation of the tags (data not shown).
DISCUSSION
In the present study we confirmed and extended our earlier analysis of the homotypic interactions of the IBDV proteins. The use of the recently refined cleavage map of the structural protein precursor allowed the detection of a novel homologous interaction for VP4 by the yeast two-hybrid system, in addition to the self-association observed earlier for pVP2, VP3 and VP5 as well as -though weaklyfor VP1.
A further characterization of the strongly interacting pVP2, VP3, VP4 and VP5 proteins was undertaken both by using the yeast two-hybrid system and by performing co-immunoprecipitation analyses of co-expressed cDNA constructs.
Through deletion mutagenesis we were able to map the self-interacting regions in all of the proteins except for VP4 which appeared to be very sensitive to modifications.
The data on VP3 allow us now to design a domain map in which the different regions of the protein involved in homomeric and heteromeric interactions can be assigned.
The IBDV capsid is an icosahedron with a T=13 lattice composed of trimeric subunits (Bottcher et al., 1997; Caston et al., 2001) . The outer face of the particle is composed of 260 trimeric VP2 clusters. Closely apposed to the inside of this protein layer are 200 Y-shaped trimeric VP3 structures. This arrangement not only predicts the existence of homomeric interactions of the two capsid proteins, their intimate association dictates the occurrence of heteromeric contacts as well. However, while the self-association of both proteins came out convincingly, we failed to detect pVP2/VP3 interactions in our assays. The reasons for this most likely relate to the assay systems that we used. The two-hybrid system, for instance, would be inadequate if we assume that the interactions only occur between the trimeric units.
Also, if such heteromeric complexes would have been formed in the co-expression system, they may not have been sufficiently stable to survive the immunoprecipitation conditions, e.g. due to the low concentration of SDS present. It is of note that VP2/VP3 complexes were also not detected in infected cell lysates (Tacken et al., 2000) and that the assembly of virus-like particles from these proteins somehow requires the VP3 protein to be 'activated', as their formation could only be achieved after modification of its carboxy terminus .
We observed strong interactions between full-length VP3 molecules in our two-hybrid assays. These interactions were subsequently narrowed down by protein truncation to the amino-terminal region of the molecule. Specifically, a polypeptide comprising residues 1-97 was identified as the domain responsible for homomeric interaction, since this region proved to interact with its full-length cognate protein in both the yeast two-hybrid and the co-immunoprecipitation assay. Interestingly, this domain is clearly distinct from the regions in the VP3 molecule known to interact with other components in the virion. VP3 has been shown by us (Tacken et al., 2000) as well as by others (Lombardo et al., 1999) to bind to the viral RNA-dependent RNA polymerase, VP1. We were able to map the domain in VP3 responsible for this interaction to the very carboxy-terminal 10 residues (Tacken et al., 2002) . In the same study we additionally demonstrated, that VP3 also interacts with both dsRNA segments of the viral genome. The domain responsible for this association has not been determined yet, but has been implicated to occur in the carboxy-terminal region as well, in a domain spanning residues 221-247, a highly basic region with interspersed proline residues (Bottcher et al., 1997; Hudson et al., 1986; Tacken et al., 2002) . Importantly, deletion of the VP1-binding domain in VP3 did not abolish VP3-dsRNA interactions (Tacken et al., 2002) nor did it affect VP3-VP3 interaction Unlike VP3 (Martinez-Torrecuadrada et al., 2000b) , (p)VP2 has been shown to have a strong tendency to self-assemble giving rise to different types of particles depending on the conditions, varying from rigid, flexible and twisted tubules to smaller or larger virus-like particles (Caston et al., 2001; Chevalier et al., 2002; Fernandez-Arias et al., 1998; Lombardo et al., 1999; Martinez-Torrecuadrada et al., 2000a; Martinez-Torrecuadrada et al., 2000b) . Detailed electron cryomicroscopy and image processing analyses of different types of particles clearly revealed the trimeric VP2 structures in which each molecule can be subdivided into three subdomains, each able of interacting in a non-equivalent fashion with another VP2 molecule of the same or of an adjoining trimer (Caston et al., 2001 ). This constellation would predict that removal of one such subdomain does not necessarily disable the interactions by the others. Our observations support this view, as the deletions of different domains of the pVP2 molecule appeared not to abolish the association capacity of the remaining polypeptides. This was also not the case after truncation of a carboxy-terminal 128-residue segment, which contains the 50-60 residues tail supposed to play a crucial role in the control of the interactions between trimers of VP2 as well as between trimers of VP2 and VP3 (Caston et al., 2001) . Without this tail domain independently expressed VP2 assembles into T=1 (Tacken et al., 2002) , while the approximate one-third amino-terminal region was presently shown to be responsible for homomeric interaction. The site for dsRNA interaction has not been precisely defined yet though has been postulated to comprise the indicated stretch of amino acids (Caston et al., 2001; Hudson et al., 1986; Tacken et al., 2002) . The graded line above the upper bar representing the VP3 polypeptide indicates the amino acid (AA) residue numbers.
capsids (Caston et al., 2001) , while this domain is essential for normal virion morphogenesis in IBDV infected cells . VP4, the viral protease, was anticipated to exhibit homologous interaction.
In IBDV infected cells this protein assembles into distinct tubular aggregates, 24-26 nm in diameter, known as type II tubules (Granzow et al., 1997) . Though the function of these structures in viral infection is still unclear, they might serve to inactivate excess protease activity, thereby preventing lethal damage to the virus or to the cells. Attempts to identify interacting domain(s) in the polypeptide failed; none of the deletions tested preserved the ability of the protein to associate with its fulllength counterpart in the yeast two-hybrid assay. Negative results in the two-hybrid assay often result from protein instability, but that appeared not to be the case here. All described fusion proteins were analyzed by immunoblotting and appeared to accumulate in high amounts and with the expected size (data not shown). Our observations are therefore most compatible with the terminal domains interacting with each other to stabilize a conformation that is required for homotypic association. Deletion of either terminus disrupts this conformation and abolishes the interaction. This is also consistent with our initial inability to detect the homotypic interaction of VP4 in the yeast two-hybrid system (Tacken et al., 2000) . The VP4 protein that we tested in those studies carried a 61 residue amino-terminal extension while lacking 34 residues at its carboxy-terminal, both due to the use of incorrect precursor cleavage sites (Fig. 1C) . Either or both these defects apparently interfered with self-association.
The exact function of VP5 is still unknown. The protein is highly basic, cysteine-rich, and its sequence is conserved among all serotype I IBDV strains (>95% identity). A VP5 deficient virus can replicate in the bursa of inoculated chickens but does not induce bursal lesions (Yao et al., 1998) . It has also been demonstrated that this VP5 deficient mutant IBDV remains closely associated with and is not efficiently released from infected cells (Yao & Vakharia, 2001) . The protein has therefore been speculated to somehow facilitate progeny virus release (Yao & Vakharia, 2001 ).
Recently, it was shown that VP5 accumulates within the host cell plasma membrane (Lombardo et al., 2000) . Expression of VP5 resulted in alteration of cell morphology, disruption of the plasma membrane, and in a drastic reduction of cell viability (Lombardo et al., 2000) . Furthermore, the protein is capable of inducing a programmed cell death response in culture cells (Yao & Vakharia, 2001) . Sequencebased topology predictions indicated that VP5 is a class II membrane protein, having an intracellular amino-terminal tail, a transmembrane helix and an extracellular carboxy-terminal region (Lombardo et al., 2000) . Interestingly, the putative self-interacting domain of VP5 that we mapped in our two-hybrid analysis to the domain comprising residues 73-90 corresponds almost exactly to the predicted transmembrane region (residues 69-88) of the protein. Due to the common α-helical structure of transmembrane domains, many are considered to form channels or pores in the membrane by a so-called 'barrel-stave' mechanism (reviewed in (Ojcius & Young, 1991) ). The observation that the plasma membrane of VP5 expressing cells was permeable not only to small molecules, but also to macromolecules such as lectin and IgG molecules (Lombardo et al., 2000) strongly supports the hypothesis that VP5 molecules indeed form pore structures within the plasma membrane. In addition, these observed changes in membrane permeability are similar to those produced in E. coli by the viral proteins E1 of hepatitis C virus, M2 of influenza virus, gp41of human immunodeficiency virus and 3AB of poliovirus, whose transmembrane domains are also thought to cause pore formation (Arroyo et al., 1995; Ciccaglione et al., 2001; Guinea & Carrasco, 1994; Lama & Carrasco, 1992; Lama & Carrasco, 1995) . The 'barrel-stave' mechanism involves three major steps: (i) binding of monomers to the membrane; (ii) insertion into the membrane to form a pore; and (iii) progressive recruitment of additional monomers to increase the pore size (Shai, 1995) . Initial assembly of monomers on the surface of the membrane must occur before the peptide is inserted, since it is energetically unfavourable for an amphipatic α-helix to traverse the membrane as a monomer. A homotypic interaction of VP5 through a self-interacting domain located within its predicted membrane-spanning region is therefore consistent with the hypothesis that VP5 molecules co-assemble at the host plasma membrane to form a pore structure. It would hence be interesting to evaluate whether mutations of conserved amino acids in the putative transmembrane region of VP5 would affect its membranepermeabilizing activity.
Shortcomings of the individual methods used in this study necessitate a cautious interpretation of data observed just by one type of assay. This is for instance obvious from those cases where we were unable to confirm protein interactions by the co-immunoprecipitation assay that had been convincingly demonstrated in the yeast system, as exemplified by some of the VP3 and all VP5 truncation constructs that were tested by both approaches. Such inconsistencies between the two techniques are frequently observed (Vidal & Legrain, 1999; Warbrick, 1997) . Our yeast two-hybrid deletion analysis of amino-and carboxyterminally truncated VP3 molecules showed that neither the first 32 nor the last 129 amino acids of VP3 were necessary for VP3-VP3 interaction. However, the strongly interacting deletion mutant VP3∆N32/C129, which lacks both these terminal domains, was found not to be efficiently co-immunoprecipitated when coexpressed with full-length VP3. On the other hand, the VP3 deletion mutant VP3∆C161, which differs from mutant VP3∆N32/C129 only by having its amino terminus intact, clearly interacted with full-length VP3 in both the two-hybrid and the co-immunoprecipitation assays. Because the two-hybrid LexA BD and B42 AD fusion proteins were stably expressed and negative for self-activation of the LEU2 and LacZ reporter genes, we attach much value to the positive results obtained with the yeast two-hybrid system. Thus, the deletion mutant VP3∆N32/C129 most likely behaved as a bona fide VP3 partner in the yeast two-hybrid system. In contrast, there are many possible causes for negative results in the immunoprecipitation assay. One is the effect of the c-Myc or HA tags used in this assay. These extensions might sterically hinder interaction of the fusion proteins or reduce their interaction strength.
Alternatively, their interaction might become destabilized by the binding of antibodies to the tags. While these considerations leave us with uncertainties about some of our -unconfirmed -observations and at the same time ask for additional, independent interaction assays, the combined results of our study provide a good basis for the further analysis of these important interactions in the future.
